chemie.pr-ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
New Data Confirms Avastin (R) as the Only Biologic to Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
16.09.2008 08:40:06
Roche Pharmaceuticals: Basel, Switzerland (ots/PRNewswire) - Avastin (bevacizumab) remains the only biologic to provide overall survival (OS) benefit when used as first-line treatment in combination with chemotherapy for patients with K-Ras wild type ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer
- Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation
- Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
- Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
- New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
- AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Cancer
- New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
- Avastin(R) Gives an Additional 4 Months of Life to Patients With one of the Most Common Types of Lung Cancer
- New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
- First Comprehensive Report on Colorectal Cancer (CRC) Care in Europe and Australia Reveals Urgent Need for Action
Zielpreisvereinbarungen könnten Kassenbudgets entlasten / Keller ...
New Data Confirms Avastin (R) as the Only Biologic to Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
Presseportal: Roche Pharmaceuticals - /K I L L K I L L K I L L -- Roche/
New Data Confirms Avastin (R) as the Only Biologic to Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
Presseportal: Pressemappen-Katalog
New Data Confirms Avastin (R) as the Only Biologic to Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
Studenten.de: New Data Confirms Avastin (R) as the Only Biologic to ...
(R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status